Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the effect of RO4607381 (900 mg daily) on HDL C in patients with CHD or a CHD risk equivalent. • To evaluate the 24-week safety profile of RO4607381. In addition to assessing the general safety profile of RO4607381, MRI imaging will be performed to evaluate potential changes in mesenteric lymph nodes.
Inclusion criteria
- CHD or CHD Risk Equivalent